Accessibility Menu
Molecular Partners Ag logo

Molecular Partners Ag

(OTC) MLLCF

Current Price$2.25
Market Cap$84.18M
Since IPO (2018)-90%
5 Year-89%
1 Year-47%
1 Month+0%

Molecular Partners Ag Financials at a Glance

Market Cap

$84.18M

Revenue (TTM)

$0.00

Net Income (TTM)

$61.66M

EPS (TTM)

$-1.98

P/E Ratio

-1.13

Dividend

$0.00

Beta (Volatility)

0.32 (Low)

Price

$2.25

Volume

105

Open

$2.25

Previous Close

$2.25

Daily Range

$2.25 - $2.25

52-Week Range

$2.25 - $4.22

MLLCF News

No articles available.

MLLCF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Molecular Partners Ag

Industry

Biotechnology

Employees

149

CEO

Patrick Amstutz, PhD

Headquarters

Schlieren, 8952, CH

MLLCF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-57%

Return on Capital

-64%

Return on Assets

-60%

Earnings Yield

-88.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$84.18M

Shares Outstanding

37.41M

Volume

105

Short Interest

0.00%

Avg. Volume

245.583

Financials (TTM)

Gross Profit

$2.15M

Operating Income

$55.46M

EBITDA

$53.28M

Operating Cash Flow

$49.55M

Capital Expenditure

$714.34K

Free Cash Flow

$50.27M

Cash & ST Invst.

$93.10M

Total Debt

$3.65M

Molecular Partners Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$513.25K

N/A

Gross Margin

0.00%

N/A

Market Cap

$84.18M

N/A

Market Cap/Employee

$532.78K

N/A

Employees

158

N/A

Net Income

$12.66M

-12.7%

EBITDA

$12.12M

-13.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$89.46M

-39.1%

Accounts Receivable

$1.30M

-49.9%

Inventory

$0.00

N/A

Long Term Debt

$2.44M

+98.8%

Short Term Debt

$1.21M

-0.9%

Return on Assets

-60.43%

N/A

Return on Invested Capital

-63.74%

N/A

Free Cash Flow

$10.91M

+18.1%

Operating Cash Flow

$10.78M

+18.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BXPHFBotanix Pharmaceuticals Limited
$0.04+0.00%
AAWHAscend Wellness Holdings, Inc.
$0.49-2.93%
HOFBFHofseth BioCare ASA
$0.17+0.00%
JWCTFJW (Cayman) Therapeutics Co. Ltd
$0.31+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$75.91+0.01%
IBITiShares Bitcoin Trust
$39.82-0.01%

Questions About MLLCF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.